JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 22 No. 9 781-786
© 1981 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Susskind, H.
Right arrow Articles by Brill, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Susskind, H.
Right arrow Articles by Brill, A. B.

Sensitivity of Kr-81m and Xe-127 in Evaluating Nonembolic Pulmonary Disease

H. Susskind, H. L. Atkins, A. G. Goldman, J. C. Acevedo, H. R. Pate, P. Richards and A. B. Brill

Brookhaven National Laboratory, Upton, New York

Correspondence: For reprints contact: Herbert Susskind, PE, Medical Dept., Brookhaven National Laboratory, Upton, NY 11973.

ABSTRACT

The relative sensitivities of Kr-81m and Xe-127 in detecting lung ventilation defects was evaluated in 80 patients with nonembolic pulmonary diseases. Krypton-81m ventilation images (500,000 count) were interdigitated with Tc-99m MAA perfusion images; both were compared with Xe-127 images. The distributions of the two gases were also compared on the basis of point-by-point computer analyses. Xenon-127 was found to be more sensitive than Kr-81m in clinical evaluations of scintiphotos—although they were equivalent by computer analyses—in indicating regions of impaired ventilation in patients with obstructive airways disease.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1981 by the Society of Nuclear Medicine.